These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34458620)

  • 1. Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA 'ecstasy' and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT).
    Islas ÁA; Moreno LG; Scior T
    Heliyon; 2021 Aug; 7(8):e07784. PubMed ID: 34458620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations.
    Islas ÁA; Scior T
    Molecules; 2022 May; 27(9):. PubMed ID: 35566327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA ("Ecstasy") in Rats and Preserves Affinity for the Serotonin Transporter (SERT).
    Sáez-Briones P; Castro-Castillo V; Díaz-Véliz G; Valladares L; Barra R; Hernández A; Cassels BK
    Front Pharmacol; 2019; 10():157. PubMed ID: 30873030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.
    Sealover NR; Felts B; Kuntz CP; Jarrard RE; Hockerman GH; Lamb PW; Barker EL; Henry LK
    Biochem Pharmacol; 2016 Nov; 120():46-55. PubMed ID: 27638414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.
    Nichols DE
    Front Psychiatry; 2022; 13():863088. PubMed ID: 35401275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural model of the human serotonin transporter in an outward-occluded state.
    Hellsberg E; Ecker GF; Stary-Weinzinger A; Forrest LR
    PLoS One; 2019; 14(6):e0217377. PubMed ID: 31251747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations.
    Zhang Y; Zheng G; Fu T; Hong J; Li F; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2020 Mar; 22(9):5132-5144. PubMed ID: 32073004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.
    Montgomery T; Buon C; Eibauer S; Guiry PJ; Keenan AK; McBean GJ
    Br J Pharmacol; 2007 Dec; 152(7):1121-30. PubMed ID: 17891159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.
    Celik L; Sinning S; Severinsen K; Hansen CG; Møller MS; Bols M; Wiborg O; Schiøtt B
    J Am Chem Soc; 2008 Mar; 130(12):3853-65. PubMed ID: 18314975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
    Rudnick G; Wall SC
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1817-21. PubMed ID: 1347426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.
    Kortagere S; Fontana AC; Rose DR; Mortensen OV
    Neuropharmacology; 2013 Sep; 72():282-90. PubMed ID: 23632081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats.
    Páleníček T; Lhotková E; Žídková M; Balíková M; Kuchař M; Himl M; Mikšátková P; Čegan M; Valeš K; Tylš F; Horsley RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():49-59. PubMed ID: 27083855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter.
    Andersen J; Ladefoged LK; Wang D; Kristensen TN; Bang-Andersen B; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2015 Nov; 6(11):1892-900. PubMed ID: 26389667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.